JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.74B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$8.51B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$6.03B |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$4.86B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.63B |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.02B |
| 3 |
Palantir
PLTR
|
+$2.14B |
| 4 |
Shopify
SHOP
|
+$2.1B |
| 5 |
Robinhood
HOOD
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.29% |
| 2 | Technology | 22.42% |
| 3 | Healthcare | 8.64% |
| 4 | Financials | 8.63% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FLXR
3726
TCW Flexible Income ETF
FLXR
$3.59B
| $2.72M | ﹤0.01% |
69,594
+35,764
| +106% | +$1.41M |
2025 Q3
2 quarters
|
|
3727
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.72B
| $2.72M | ﹤0.01% |
32,741
-557
| -2% | -$49.1K |
2019 Q4
25 quarters
|
|
3728
PUT
Southwest Airlines
LUV
$20.8B
| $2.72M | ﹤0.01% |
75,000
-75,000
| -50% | -$3.39M |
2025 Q4
1 quarter
|
|
3729
Avantis Emerging Markets ex-China Equity ETF
AVXC
$469M
| $2.72M | ﹤0.01% |
41,744
-2,964
| -7% | -$206K |
2024 Q4
5 quarters
|
|
3730
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$273M
| $2.72M | ﹤0.01% |
62,995
-5,236
| -8% | -$233K |
2022 Q4
13 quarters
|
|
3731
CALL
Incyte
INCY
$23.4B
| $2.71M | ﹤0.01% |
+30,000
| New | +$2.99M |
2026 Q1
0 quarters
|
|
|
3732
PUT
Incyte
INCY
$23.4B
| $2.71M | ﹤0.01% |
+30,000
| New | +$2.99M |
2026 Q1
0 quarters
|
|
|
CTO
3733
CTO Realty Growth
CTO
$770M
| $2.71M | ﹤0.01% |
146,898
+13,437
| +10% | +$251K |
2017 Q4
33 quarters
|
|
3734
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $2.71M | ﹤0.01% |
14,033
+315
| +2% | +$65.2K |
2013 Q2
51 quarters
|
|
3735
Avalo Therapeutics
AVTX
$804M
| $2.71M | ﹤0.01% |
194,391
+149,960
| +338% | +$2.34M |
2023 Q4
9 quarters
|
|
3736
The Greenbrier Companies
GBX
$1.26B
| $2.71M | ﹤0.01% |
52,388
-46,258
| -47% | -$2.44M |
2014 Q3
46 quarters
|
|
|
RGEF
3737
Rockefeller Global Equity ETF
RGEF
$833M
| $2.7M | ﹤0.01% |
+92,942
| New | +$2.91M |
2026 Q1
0 quarters
|
|
|
TBCH
3738
Turtle Beach Corp
TBCH
$251M
| $2.7M | ﹤0.01% |
266,732
+55,679
| +26% | +$692K |
2020 Q2
23 quarters
|
|
3739
Inspire Medical Systems
INSP
$2.02B
| $2.7M | ﹤0.01% |
53,615
+8,227
| +18% | +$576K |
2018 Q2
31 quarters
|
|
3740
Stepan Co
SCL
$1.43B
| $2.7M | ﹤0.01% |
54,243
-11,369
| -17% | -$609K |
2013 Q2
51 quarters
|
|
3741
Helen of Troy
HELE
$623M
| $2.7M | ﹤0.01% |
192,769
+10,644
| +6% | +$186K |
2013 Q2
51 quarters
|
|
3742
Trupanion
TRUP
$1.03B
| $2.7M | ﹤0.01% |
104,671
+75,086
| +254% | +$2.24M |
2017 Q3
34 quarters
|
|
|
HPP
3743
Hudson Pacific Properties
HPP
$623M
| $2.7M | ﹤0.01% |
452,138
-122,881
| -21% | -$944K |
2014 Q4
45 quarters
|
|
3744
State Street SPDR S&P Regional Banking ETF
KRE
$3.61B
| $2.7M | ﹤0.01% |
42,425
-1,220,162
| -97% | -$82.5M |
2013 Q2
51 quarters
|
|
3745
Kodiak Sciences
KOD
$5.94B
| $2.68M | ﹤0.01% |
79,708
+61,803
| +345% | +$1.6M |
2018 Q4
29 quarters
|
|
3746
CALL
QuidelOrtho
QDEL
$739M
| $2.68M | ﹤0.01% |
+175,500
| New | +$4.31M |
2026 Q1
0 quarters
|
|
|
AEXA
3747
American Exceptionalism Acquisition Corp
AEXA
$550M
| $2.67M | ﹤0.01% |
246,377
| – | – |
2025 Q3
2 quarters
|
|
3748
JPMorgan High Yield Municipal ETF
JMHI
$283M
| $2.67M | ﹤0.01% |
53,676
-1,387
| -3% | -$70K |
2023 Q3
10 quarters
|
|
3749
Universal Corp
UVV
$1.05B
| $2.66M | ﹤0.01% |
50,219
+438
| +0.9% | +$23.6K |
2013 Q2
51 quarters
|
|
3750
Invesco S&P MidCap Momentum ETF
XMMO
$7.22B
| $2.66M | ﹤0.01% |
19,134
+11,498
| +151% | +$1.66M |
2023 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2026 Portfolio in Review
As of Q1 2026, JP Morgan Chase held 8,085 positions worth $1.56T, down 2.2% from $1.59T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase deployed $90.5B of net new capital in Q1 2026, opening 727 new positions and adding to 3,199 existing holdings. Its largest new stake was iShares International Country Rotation Active ETF: 15,443,505 shares worth $481M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $8.63B trimmed.
- JP Morgan Chase's largest Q1 2026 buy was iShares International Country Rotation Active ETF: 15,443,505 shares worth $481M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $9.74B increase.
- JP Morgan Chase's biggest Q1 2026 reduction was Microsoft, cutting an estimated $8.63B.
- JP Morgan Chase fully exited CyberArk in Q1 2026, selling an estimated $307M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.56T portfolio in Q1 2026.
- JP Morgan Chase opened 727 new positions and closed 604 in Q1 2026.
- JP Morgan Chase's portfolio value fell 2.2% quarter-over-quarter to $1.56T.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.